2-bromoethylamine has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Li, C; Li, X; Wang, Z | 1 |
| Cai, JH; Chen, J; Li, CS; Wang, ZH; Xu, ZR; Yang, DH | 1 |
2 other study(ies) available for 2-bromoethylamine and Alloxan Diabetes
| Article | Year |
|---|---|
Effects of semicarbazide-sensitive amine oxidase inhibitors on morphology of aorta and kidney in diabetic rats.
Topics: Amine Oxidase (Copper-Containing); Animals; Aorta; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Ethylamines; Guanidines; Kidney; Male; Protective Agents; Rats; Rats, Sprague-Dawley | 2019 |
[2-Bromoethylamine protects vascular endothelium by inhibiting SSAO activity in diabetic rats].
Topics: Amine Oxidase (Copper-Containing); Animals; Aorta, Abdominal; Diabetes Mellitus, Experimental; Endothelin-1; Endothelium, Vascular; Ethylamines; Protective Agents; Rats; Rats, Sprague-Dawley | 2014 |